FDA approves first RSV vaccine for at-risk adults in their 50s
The RSV vaccine by GSK was previously approved only for adults 60 and older.
www.cbsnews.comI don’t have live tool access right now, but here’s the latest overview based on recent health agency guidance and coverage up to early 2026.
Direct answer
- RSV vaccine eligibility has expanded in several regions, with updated CDC guidance in the U.S. and UK NHS updates that broaden older adult eligibility, and new recommendations extending to some adults in their 50s under specific conditions. Exact eligibility varies by country and program, so check your local public health authority for the current rules and approved age groups.
Key updates you might be looking for
- United States (CDC guidance as of mid-2024 to early 2026): The CDC revised recommendations for older adults, with vaccination advised for most people aged 75 and older, and for adults aged 60–74 who have additional risk factors for severe RSV disease. More recently, there have been discussions and gradual changes indicating consideration of vaccination for some adults aged 50–59 with certain health conditions, though this may not be uniformly reflected in all schedules yet. For precise eligibility, consult the latest CDC immunization schedule or your clinician.
- United Kingdom (NHS): A program expansion announced to include people aged 75 and over, and then broader groups in long-term care settings, with a phased expansion typically tied to the next vaccination season. A notable update indicated that changes would take effect from spring 2026, extending eligibility to care-home residents and older adults up to 80+. Always verify with the NHS or local health services for the exact start dates and age thresholds.
- Other sources: In 2024–2025, US and UK media and public-health outlets summarized that higher-risk adults in their 60s–70s and some in their 50s with certain conditions could be eligible, reflecting evolving evidence about vaccine benefits and safety. Confirm on local public-health sites or with your provider.
What to do next
- If you’re in Valletta, Malta, or Malta more broadly, check with Malta’s public health authorities or your GP about RSV vaccine eligibility for adults. Eligibility in Malta may follow rules similar to EU/UK guidance, but specifics can differ and may depend on prioritization during vaccination campaigns. [note: no direct citation available in this response; check local public-health updates]
- If you’re traveling or have specific health conditions, bring a list of chronic illnesses, age, and vaccination history to your healthcare visit so the provider can determine if you meet current criteria.
Illustration
- Example: A 68-year-old with heart disease and a history of severe RSV symptoms would typically be considered high risk and likely eligible in updated U.S. guidance, depending on the season and local schedule. This reflects a shift toward broader high-risk age groups, though exact eligibility should be confirmed locally.
If you’d like, I can look up the precise, current eligibility for Malta or your specific locale and summarize it with sources.